Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Hong Kong
· Delayed Price · Currency is HKD 6.77
+0.16 (2.42%)
At close: Apr 29, 2026
HKG:2427 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 88.45 | 155.74 | 156.07 | 177.11 | 211.08 | Upgrade
|
| Revenue Growth (YoY) | -43.21% | -0.21% | -11.88% | -16.09% | 14.45% | Upgrade
|
| Cost of Revenue | 66.32 | 92.95 | 70.67 | 96.14 | 135.38 | Upgrade
|
| Gross Profit | 22.13 | 62.79 | 85.41 | 80.98 | 75.7 | Upgrade
|
| Selling, General & Admin | 34.23 | 31.57 | 40.9 | 32.55 | 33.19 | Upgrade
|
| Research & Development | 5.79 | 4.07 | 1.53 | 0.54 | 0.4 | Upgrade
|
| Operating Expenses | 43.84 | 38.83 | 46.7 | 33.29 | 33.51 | Upgrade
|
| Operating Income | -21.72 | 23.95 | 38.7 | 47.68 | 42.19 | Upgrade
|
| Interest Expense | -0.52 | -0.71 | -0.86 | -1.03 | -0.6 | Upgrade
|
| Interest & Investment Income | 0.06 | 0.72 | 0.84 | 0.03 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.31 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 6.39 | 2.35 | -0.03 | 1.7 | 1.03 | Upgrade
|
| EBT Excluding Unusual Items | -16.09 | 26.31 | 38.65 | 48.38 | 42.66 | Upgrade
|
| Gain (Loss) on Sale of Assets | -10.23 | - | - | - | - | Upgrade
|
| Asset Writedown | -5.07 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.01 | - | - | -18.42 | -9.6 | Upgrade
|
| Pretax Income | -31.38 | 26.31 | 38.65 | 29.96 | 33.06 | Upgrade
|
| Income Tax Expense | -1.42 | 8.86 | 10.73 | 11.68 | 9.99 | Upgrade
|
| Earnings From Continuing Operations | -29.96 | 17.45 | 27.92 | 18.29 | 23.07 | Upgrade
|
| Minority Interest in Earnings | 0.25 | -0.25 | -0.36 | -0.34 | -0.13 | Upgrade
|
| Net Income | -29.72 | 17.2 | 27.57 | 17.94 | 22.94 | Upgrade
|
| Net Income to Common | -29.72 | 17.2 | 27.57 | 17.94 | 22.94 | Upgrade
|
| Net Income Growth | - | -37.59% | 53.63% | -21.76% | -21.03% | Upgrade
|
| Shares Outstanding (Basic) | 936 | 939 | 950 | 766 | 757 | Upgrade
|
| Shares Outstanding (Diluted) | 936 | 950 | 950 | 766 | 757 | Upgrade
|
| Shares Change (YoY) | -1.47% | - | 24.00% | 1.19% | - | Upgrade
|
| EPS (Basic) | -0.03 | 0.02 | 0.03 | 0.02 | 0.03 | Upgrade
|
| EPS (Diluted) | -0.03 | 0.02 | 0.03 | 0.02 | 0.03 | Upgrade
|
| EPS Growth | - | -36.89% | 23.89% | -22.68% | - | Upgrade
|
| Free Cash Flow | - | -3.85 | 1.54 | -0.01 | -4.72 | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | 0.00 | - | -0.01 | Upgrade
|
| Dividend Per Share | - | - | 0.019 | 0.019 | - | Upgrade
|
| Dividend Growth | - | - | 2.62% | - | - | Upgrade
|
| Gross Margin | 25.02% | 40.31% | 54.72% | 45.72% | 35.86% | Upgrade
|
| Operating Margin | -24.55% | 15.38% | 24.80% | 26.92% | 19.99% | Upgrade
|
| Profit Margin | -33.60% | 11.05% | 17.66% | 10.13% | 10.87% | Upgrade
|
| Free Cash Flow Margin | - | -2.47% | 0.99% | -0.01% | -2.23% | Upgrade
|
| EBITDA | -15.15 | 30.52 | 44.34 | 51.85 | 45.46 | Upgrade
|
| EBITDA Margin | -17.13% | 19.59% | 28.41% | 29.28% | 21.54% | Upgrade
|
| D&A For EBITDA | 6.56 | 6.56 | 5.64 | 4.17 | 3.28 | Upgrade
|
| EBIT | -21.72 | 23.95 | 38.7 | 47.68 | 42.19 | Upgrade
|
| EBIT Margin | -24.55% | 15.38% | 24.80% | 26.92% | 19.99% | Upgrade
|
| Effective Tax Rate | - | 33.67% | 27.76% | 38.97% | 30.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.